Broadfin Capital’s Protalix BioTherapeutics PLX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-202,527	Closed	-$1.3M	–	67
2016 Q2	$1.3M	Sell	202,527 -136,102	-40%	-$871K	0.13%	62
2016 Q1	$2.85M	Buy	338,629 +4,772	+1%	+$40.1K	0.27%	58
2015 Q4	$3.41M	Buy	+333,857	New	+$3.41M	0.21%	69